Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
PARP inhibition combined with a T-cell receptor β chain-directed antibody fusion molecule drives polyclonal antitumor immunity and tumor regression.
Journal: Journal for immunotherapy of cancer
Published: June 18, 2026
TIME for Endometrial Cancer: Advancements and Challenges in Therapeutic Targets for the Endometrial Cancer Tumor Immune Microenvironment.
Journal: Cancer immunology research
Published: May 08, 2025
Distinct effects of sacituzumab govitecan and berzosertib on DNA damage response in ovarian cancer.
Journal: iScience
Published: March 19, 2024
B cell-specific deficiencies in mTOR limit humoral immune responses.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 17, 2013
Showing 1-4 of 4
Last Updated: 09/26/2026